Fresenius SE





Medicine & Research - 2009

29.10.2009Fresenius Medical Care announces presentation of first results from the CALMAG study for phosphate binder OsvaRen®
PDF Text as PDF-file
13.10.2009Fresenius Medical Care introduces programme for improved PD therapy
PDF Text as PDF-file
22.05.2009New Renal Pharma Website from Fresenius Medical Care – Interactive Online Training in Bone Metabolism
PDF Text as PDF-file
23.04.2009Fresenius Biotech receives approval for Removab® by European Commission - First Drug worldwide for Treatment of Malignant Ascites
PDF Text as PDF-file
18.02.2009EMEA-Committee for Medicinal Products for Human Use issues positive opinion for Removab® (catumaxomab) for the treatment of malignant ascites
PDF Text as PDF-file